The Effectiveness of Omalizumab Treatment in Real-Life is Lower in Patients with Chronic Urticaria Longer than 18 Months' Evolution and Prior Immunosuppressive Treatment. [electronic resource]
Producer: 20191223Description: 289-296 p. digitalISSN:- 2173-5778
- Adolescent
- Adult
- Aged
- Anti-Allergic Agents -- therapeutic use
- Chronic Disease
- Female
- Histamine H1 Antagonists -- therapeutic use
- Humans
- Immunosuppressive Agents -- therapeutic use
- Male
- Middle Aged
- Omalizumab -- therapeutic use
- Pragmatic Clinical Trials as Topic
- Registries
- Remission Induction
- Retrospective Studies
- Treatment Outcome
- Urticaria -- drug therapy
- Young Adult
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.